Atrion Corporation

Atrion Corporation is engaged in developing and manufacturing products, primarily for medical applications. The Company supplies medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. The Company has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology.

Company Growth (employees)
Plymouth Meeting, US
Size (employees)
520 (est)
Atrion Corporation was founded in 1944 and is headquartered in Plymouth Meeting, US

Atrion Corporation Office Locations

Atrion Corporation has an office in Plymouth Meeting
Plymouth Meeting, US (HQ)
527 Plymouth Rd
Show all (1)

Atrion Corporation Financials and Metrics

Atrion Corporation Financials

Atrion Corporation's revenue was reported to be $143.5 m in FY, 2016

Revenue (Q2, 2017)

36.2 m

Gross profit (Q2, 2017)

17.7 m

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

10 m

EBIT (Q2, 2017)

10.2 m

Market capitalization (23-Feb-2018)

1 b

Cash (30-Jun-2017)

20.2 m
Atrion Corporation's current market capitalization is $1 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


132 m140.8 m145.7 m143.5 m

Revenue growth, %


Cost of goods sold

74.8 m75.9 m

Gross profit

71 m67.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


37.7 m37.4 m36.2 m36.1 m37.8 m38.5 m36.2 m

Cost of goods sold

18.9 m19 m18.7 m18.9 m20.2 m19.9 m18.5 m

Gross profit

18.8 m18.4 m17.6 m17.2 m17.6 m18.6 m17.7 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


28.6 m20.8 m28.3 m20 m


26.3 m28 m29.8 m29 m

Current Assets

90.3 m74.1 m78.3 m94.1 m


9.7 m9.7 m9.7 m9.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


30.7 m17.2 m23.5 m26.9 m15.9 m19.6 m23.4 m27.9 m30.8 m23.7 m17.5 m20.2 m

Accounts Receivable

16.2 m18.6 m16.4 m18.4 m21.4 m21.2 m19.6 m21.7 m18.8 m20.1 m20.7 m19.7 m


26.5 m26.3 m27.2 m28.4 m26.7 m27.5 m29.2 m30.5 m31.2 m30.1 m30.4 m30 m

Current Assets

84.1 m90 m89.1 m95.3 m69.2 m71.9 m75.7 m82.1 m85.2 m91.7 m99.6 m103 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

26.6 m27.8 m28.9 m27.6 m

Depreciation and Amortization

8.6 m8.7 m8.8 m9 m

Accounts Receivable

(1.1 m)(2.8 m)371 k(546 k)


(2.5 m)(1.8 m)(1.7 m)756 k
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

20.8 m7.2 m14.1 m21.8 m7.6 m15.1 m22.9 m6.9 m14.4 m22 m10 m20 m

Depreciation and Amortization

6.4 m2.3 m4.5 m6.7 m2.2 m4.5 m6.7 m2.2 m4.4 m6.7 m2.1 m4.2 m

Accounts Receivable

(3.1 m)(4.5 m)(2.2 m)(4.2 m)(4.4 m)(4.3 m)(2.6 m)(5.1 m)(2.2 m)(3.5 m)(3.5 m)(2.5 m)


(2.7 m)(59 k)(942 k)(2.1 m)1.3 m569 k(1.2 m)(697 k)(1.4 m)(285 k)(1.3 m)(950 k)
Y, 2017

Financial Leverage

1.1 x
Show all financial metrics

Atrion Corporation Market Value History

Atrion Corporation's Web-traffic and Trends

Atrion Corporation Company Life and Culture

You may also be interested in